Best Longevity Apps Compared 2026: DAOM Ranked Review

Longevity apps in 2026 fall into three categories biometric trackers functional medicine lab interpreters and integrated coaching platforms. Blueprint Function Health SuperAge and AI Longevity Pro are the four most credible. Each occupies a different market position.

Reviewed by Dr. Brandon Bright, DAOM, LAc
Doctor of Acupuncture and Oriental Medicine, functional medicine clinician, and founder of Holistic Dr. Bright in Tustin, California.

Why a Comparison Matters Now

Longevity is moving from wellness marketing to measurable biomarkers. The apps that track and interpret functional labs HRV epigenetic age biological age are now competing on outcome data not engagement vanity metrics.

Side-by-Side 2026 Snapshot

Blueprint by Bryan Johnson: Biometric tracker focus. Integrates wearables and biometric devices. Tracks HRV sleep metrics heart rate. Does not interpret functional labs. Cost 1000-2000 per year. Best for quantified-self enthusiasts who want obsessive biometric tracking without clinical interpretation.

Function Health: Lab interpreter focus. Orders comprehensive panels from Quest LabCorp. AI-powered interpretation and trends. Does not integrate wearables. Cost 500-1000 per year plus lab costs. Best for patients who want functional labs without a clinician.

SuperAge: Epigenetic age testing focus. DNA methylation clocks GrimAge PhenoAge DunedinPACE. Tracks biological age progression. Recommends lifestyle interventions. Does not integrate wearables or functional labs directly. Cost 300-500 per test per year. Best for longevity-focused patients wanting the single metric that predicts lifespan.

AI Longevity Pro: Integrated clinician-supervised platform. Combines biometric tracking functional lab interpretation epigenetic clocks and DAOM clinician coordination. Reads PDFs from any lab source. Integrates Oura Whoop Apple Watch. Coordinates with prescribing MD/NP for peptide therapy. Launching mid-to-late May 2026. Cost TBD but designed for premium practitioners and sophisticated patients. Best for patients who want the full stack coordinated by a licensed clinician.

What Each App Actually Does Well

Blueprint: Obsessive biometric collection and pretty dashboards. If you want to know your HRV sleep metrics and body composition to decimal precision Blueprint wins.

Function Health: Makes functional labs accessible without a clinician. If you want hs-CRP ferritin homocysteine labs interpreted without seeing a doctor this is the path.

SuperAge: The single most predictive longevity metric biological age. If you want to know your actual cellular age independent of chronological age SuperAge is unmatched.

AI Longevity Pro: Coordination across all four layers biometrics labs biological age and clinical supervision. If you want one app that talks to your clinician reads your lab PDFs tracks your wearable and interprets your epigenetic age this is the only option in 2026.

When To Use Which Decision Framework

Use Blueprint if: You are a quantified-self enthusiast willing to obsess over metrics and you have a clinician separately interpreting them.

Use Function Health if: You want functional labs without a clinician and you are comfortable with AI interpretation without human review.

Use SuperAge if: Your only goal is to know your biological age and track whether interventions move it.

Use AI Longevity Pro if: You want a licensed clinician supervising the full longevity stack and you value coordination over data quantity.

Common Mistakes I See

Using Blueprint without a clinician interpreting the data. Biometrics without functional medicine context is vanity. Using Function Health as a replacement for clinical care. Using SuperAge alone without lifestyle intervention. Not realizing that biological age is trackable and moveable within 3-12 months when you have a real protocol.

Conclusion

Longevity apps in 2026 are specializing. Pick the tool that matches your goal and your willingness to work with a clinician. If you want the full integrated stack AI Longevity Pro launches mid-to-late May 2026. Join the waitlist if you want clinical-supervised longevity tracking.